Abstract
Wide variability exists with host response to SARS-CoV-2 infection among individuals. Circulatory micro RNAs (miRNAs) are being recognized as promising biomarkers for complex traits, including viral pathogenesis. We hypothesized that circulatory miRNAs at 48 h post hospitalization may predict the length of stay (LOS) and prognosis of COVID-19 patients. Plasma miRNA levels were compared between three groups: (i) healthy volunteers (C); (ii) COVID-19 patients treated with remdesivir (an antiviral) plus dexamethasone (a glucocorticoid) (with or without baricitinib, a Janus kinase inhibitor) on the day of hospitalization (I); and COVID-19 patients at 48 h post treatment (T). Results showed that circulatory miR-6741-5p expression levels were significantly different between groups C and I (p < 0.0000001); I and T (p < 0.0000001); and C and T (p = 0.001). Our ANOVA model estimated that all patients with less than 12.42 Log2 CPM had a short LOS, or a good prognosis, whereas all patients with over 12.42 Log2 CPM had a long LOS, or a poor prognosis. In sum, we show that circulatory miR-6741-5p may serve as a prognostic biomarker effectively predicting mortality risk and LOS of hospitalized COVID-19 patients.
Funder
federal COVID-19 relief funds
Subject
Virology,Infectious Diseases
Reference55 articles.
1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review;Feng;Mol. Cancer,2020
2. Predicting the mutational drivers of future SARS-CoV-2 variants of concern;Maher;Sci. Transl. Med.,2022
3. Taste and smell as chemosensory dysfunctions in COVID-19 infection;Passarelli;Am. J. Dent.,2020
4. Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV;Meo;Eur. Rev. Med. Pharmacol. Sci.,2020
5. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients;Li;J. Med. Virol.,2020